Ƶ

header-logo
GettyImages-609179959-hero

Ƶ Human Induced Pluripotent Stem Cell (iPSC) Program

To advance translational and precision medicine research, the CVRC has established the Human Induced Pluripotent Stem Cell (iPSC) Program funded by the Advancing a Healthier Wisconsin Endowment (2019-2022) and the Ƶ Dean’s Program Development funds (2023-Present). Over 600 square feet within the center provides quality iPSCs from a matching biorepository, consisting of somatic cells obtained from patient’s representative of the region/community in which we serve. The core is brought to you by a collaboration between the Cardiovascular Research Center, Department of Physiology and the Department of Pediatrics, Cardiology.

The Core Offers:

  • Human iPSC reprogramming from peripheral blood monocytes or fibroblasts (skin biopsy)
  • Human iPSC cell line differentiation services into endothelial cells, cardiomyocytes, or vascular smooth muscle cells
  • iPSC CRISPR gene knockout/knock-in or single nucleotide editing
  • Premade cell products from bank or select validated external sources
  • Methodological development (e.g., organoids, additional cell types)
  • Training for laboratory staff and pre/post-doctoral trainees on these methodologies
  • And more!

iPSC Staff 

headshot

Chun Liu, PhD

Assistant Professor

chunliu@mcw.edu

headshot

Bradley Miller

Cardiovascular iPSC Research Technologist

bmiller@mcw.edu

headshot

Abigail Multerer

Cardiovascular iPSC Research Technologist

amulterer@mcw.edu

For services, contact